StonvexLoading…
StonvexStonvexStonvexCore line items from OPFI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $381.18M | $321.48M | $273.18M | $216.96M |
Operating Income | $166.68M | $94.54M | $46.35M | $-6.34M |
Net Income | $26.33M | $7.26M | $-1.00M | $7.10M |
EPS (Diluted) | $0.99 | $0.36 | $-0.06 | $0.05 |
Total Assets | $754.09M | $641.17M | $601.54M | $579.84M |
Total Liabilities | $445.21M | $406.96M | $407.51M | $420.69M |
Cash & Equivalents | $49.45M | $61.34M | $31.79M | $16.24M |
Free Cash Flow OCF − CapEx | $382.19M | $310.80M | $287.15M | $230.05M |
Shares Outstanding | 26.51M | 20.15M | 16.39M | 84.26M |